Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,997 | 173,025 | 144,049 | 291,049 | 300,789 |
| Marketable Securities | N/A | N/A | N/A | N/A | 282 |
| Receivables | 67,766 | 80,996 | 75,804 | 64,073 | 72,349 |
| Inventories | 40,515 | 46,846 | 49,653 | 55,897 | 70,807 |
| Other current assets | 1,992 | 2,136 | 2,821 | 2,933 | 2,432 |
| TOTAL | $304,999 | $323,538 | $296,446 | $443,511 | $454,591 |
| Non-Current Assets | |||||
| PPE Net | 361 | 161 | 180 | 170 | 165 |
| Investments And Advances | 529,531 | 433,001 | 455,865 | 403,013 | 489,111 |
| Intangibles | 254,750 | 258,238 | 276,260 | 279,632 | 274,484 |
| Other Non-Current Assets | 98,463 | 103,303 | 101,017 | 105,171 | 109,361 |
| TOTAL | $883,105 | $794,703 | $833,322 | $787,986 | $873,121 |
| Total Assets | $1,188,104 | $1,118,241 | $1,129,768 | $1,231,497 | $1,327,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 96,193 | N/A |
| Accounts payable and accrued liabilities | 3,783 | 4,592 | 5,933 | 2,939 | 3,805 |
| Accrued Expenses | 5,999 | 8,896 | 5,056 | 12,381 | 12,175 |
| TOTAL | $36,183 | $39,398 | $38,137 | $134,968 | $163,884 |
| Non-Current Liabilities | |||||
| Long Term Debt | 445,718 | 445,201 | 444,692 | 444,180 | 443,679 |
| Deferred Revenues | 1,548 | 3,254 | 2,094 | 2,094 | 2,849 |
| Other Non-Current Liabilities | 78,710 | 78,555 | 80,054 | 80,790 | 114,597 |
| TOTAL | $524,428 | $523,756 | $530,138 | $530,741 | $522,460 |
| Total Liabilities | $560,611 | $563,154 | $568,275 | $665,709 | $686,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,087 | 65,098 | 65,504 | 68,126 | 69,783 |
| Common Shares | 644 | 653 | 659 | 692 | 698 |
| Retained earnings | -86,720 | -168,766 | -170,046 | -204,911 | -136,597 |
| Other shareholders' equity | 171 | 171 | 171 | 171 | 171 |
| TOTAL | $627,493 | $555,087 | $561,493 | $565,788 | $641,368 |
| Total Liabilities And Equity | $1,188,104 | $1,118,241 | $1,129,768 | $1,231,497 | $1,327,712 |